Premium
Is angiogenesis still an attractive target in metastatic castration‐resistant prostate cancer?
Author(s) -
Fay André P.,
Bellmunt Joaquim
Publication year - 2015
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.13070
Subject(s) - medicine , angiogenesis , prostate cancer , bevacizumab , docetaxel , enzalutamide , oncology , sunitinib , endoglin , cancer , vascular endothelial growth factor , cabazitaxel , metastasis , cancer research , chemotherapy , androgen deprivation therapy , vegf receptors , androgen receptor , stem cell , biology , cd34 , genetics